Abstract
Central Nervous System (CNS) Cancers, despite their low incidence rates, are highly lethal and clinically heterogeneous tumors. The vast majority of primary CNS tumors are diagnosed as gliomas, followed by Meningiomas and other less common types such as Craniopharyngiomas, Hemangiomas and Gangliogliomas. To date, the available biomarkers are not enough to underscore the characteristics th…